To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Hitachi and Takeda to Establish "Hitachi Inspharma, Ltd." for Information System Support for Takeda
02-22-2006: Hitachi, Ltd. and Takeda Pharmaceutical Company Limited announced that both parties established a joint venture "Hitachi Inspharma, Ltd." for information system support in which Hitachi and Takeda owns 66% and 34% shares respectively.
The newly established company will start its operation on April 1, 2006, which is entrusted with the development and maintenance of Takeda's information system. The company will also develop information system packages and applications specifically designed for pharmaceutical industry, and it is aiming for the industry-wide expansion of that business in the future.
Watchlist
This is where you can add this news to your personal favourites
- Hitachi
- Takeda
- Takeda Pharmaceutical
- Takeda Pharmaceuticals
- joint ventures
- 1Arkema speeds up its development in Asia and in green chemistry with the closing of the acquisition of Hipro Polymers and Casda Biomaterials
- 2Bayer CO2 project among best ideas for the future
- 3AkzoNobel further strengthens its global MCA position
- 4BASF increases prices for ethanolamines in Europe
- 5Solvay acquires Alexandria Sodium Carbonate company in Egypt
- 6Former Lufthansa building renamed “LANXESS Tower”
- 7LANXESS expands Jhagadia site to serve booming Indian market
- 8Largest and most efficient BOPP line for Africa
- 9Rhodia and Avantium to jointly develop biobased polyamides
- 10Oxygen molecule survives to enormously high pressures
- 1Baytron P®– Gateway to a new generation of polymers
- 2Rhodia and Avantium to jointly develop biobased polyamides
- 3Solvay acquires Alexandria Sodium Carbonate company in Egypt
- 4REACH Candidate List of Substances of Very High Concern for Authorisation Grows
- 5AkzoNobel selects Tebodin for the conversion of the chlorine plant in Frankfurt
- 6AkzoNobel doubles dimethylether production
- 7Are you certain, Mr. Heisenberg?
- 8BASF invests $50 million to acquire equity ownership position in Sion Power
- 9Bayer MaterialScience commissions new hydrogenation technical center
- 10Illinois Tool Works Inc. acquires AppliChem GmbH
- 1Evonik Industries’ Coatings & Additives announces price increases
- 2Solvay acquires Alexandria Sodium Carbonate company in Egypt
- 3Baytron P®– Gateway to a new generation of polymers
- 4REACH Candidate List of Substances of Very High Concern for Authorisation Grows
- 5Electrochemical extraction of silicon: new approach for a more environmentally friendly large-scale process?
- 6Drew Industrial Division of Ashland Specialty Chemical Company purchases industrial water-treatment business of London-based Fer
- 7LG-DOW Polycarbonate Plant Starts Production in Korea to Effectively Meet Regional Needs
- 8Largest and most efficient BOPP line for Africa
- 9Caflon® surfactants from Univar as substitutes for banned nonylphenol ethoxylates
- 10New study confirms length of immunity conferred by Twinrix®, only combination Hepatitis A and B vaccine
- New cooperation with Brenntag GmbH and Colonial Chemical, Inc.
- Roquette and Rhodia Acetow sign joint development agreement for the elaborat ...
- Evocatal and RohnerChem announce strategic partnership for enzymatic chemist ...
- Wacker Signs Partnership Agreement with Spanish Silicones Compounder Silicon ...
- From seaweed to biofuels
- Taminco reaches agreement with Akzo Nobel -
- Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies - - AbD Serotec will use proprietary technology to generate antibodies against novel research targets provided by Sigma-Aldrich
- Chemists create two-armed nanorobotic device to maneuver world's tiniest particles -
- Kaken Pharmaceutical Co., Ltd. and ChemDiv, Inc. partner in Drug Discovery Deal -
- Eisai Establishes New Manufacturing Subsidiary in United Kingdom -
